Experimental Therapeutics Medicinal Chemistry
Ended Master IDIQ Awarded
- Federal agency
-
Medical Command
- Awardees
- 4
- Task orders
- 5
- Obligated
- $373,167
Vehicle facts
- Opportunity
-
- W81XWH18R0012 Solicitation number
- Agency
-
- Medical Command Department of the Army, Department of Defense
- Combined task order value
- $373,167 Current and potential, with all options
- Last date to order 100% complete
- Shared ceiling 15% used
- $2,500,000.00
IDV award and task order details come from SAM.gov/FPDS.
About this vehicle
The Department of the Army Medical Command established this Master IDIQ for non-personal services supporting experimental therapeutics medicinal chemistry at the Walter Reed Army Institute of Research in Silver Spring, Maryland on January 18, 2018. The vehicle is closed to new orders as of January 17, 2023, and all ordering authority has expired.
This vehicle contracted purification and characterization of organic compounds. All five task orders awarded under the IDIQ were firm fixed price delivery orders placed between April 2018 and December 2018, with completion dates in 2018 and 2019. The work was chemical synthesis, analysis, and characterization performed at WRAIR's Silver Spring facility.
Aapharmasyn LLC dominated the vehicle, capturing three of five orders totaling $178 thousand in combined potential value (48 percent of the vehicle's $373 thousand total). Hager Biosciences, LLC and Organix Chemistry Solutions LLC each held one order, at $142 thousand and $54 thousand respectively. No set-asides were used; all awards were unrestricted.
The Department of the Army Medical Command placed three orders ($213 thousand), while the Defense Health Agency placed two ($160 thousand). Task orders ranged from approximately $18 thousand to $142 thousand in ceiling value, with most orders sized between $53 thousand and $82 thousand.
The vehicle's $2.5 million shared ceiling was never fully obligated. Of the $373 thousand in combined potential value across all five task orders, the entire amount was obligated by December 2018. Ordering activity concentrated in a single year (2018), with no subsequent awards recorded. The vehicle closed to new orders more than three years ago and represents a completed, narrow-scope effort rather than an active platform for ongoing competitive pursuits.
Description
This Master IDIQ is for Non-Personal Services for Experimental Therapeutics Medicinal Chemistry Tasks for the Walter Reed Army Institute of Research (WRAIR) in Silver Spring, MD. Service includes purification and characterization of organic compounds as needed.
IDV awards
Latest task orders
| Task order | Awardee | Awarding agency | Obligated | Last action |
|---|---|---|---|---|
| Experimental therapeutics medicinal chem | Hager Biosciences, LLC | MEDCOM | $141,679 | |
| Experimental therapeutics medicinal chem | Aapharmasyn LLC | MEDCOM | $82,000 | |
| Experimental therapeutics medicinal chem | Aapharmasyn LLC | MEDCOM | $77,780 | |
| Experimental therapeutics medicinal chem | Organix Chemistry Solutions LLC | MEDCOM | $53,750 | |
| Experimental therapeutics medicinal chem | Aapharmasyn LLC | MEDCOM | $17,958 |
Top awardees by obligations
| Rank | Awardee | Obligated | Share |
|---|---|---|---|
| 1 | Aapharmasyn LLC | $177,738 | 48% |
| 2 | Hager Biosciences, LLC | $141,679 | 38% |
| 3 | Organix Chemistry Solutions LLC | $53,750 | 14% |
Top funding agencies by obligations
| Rank | Funding agency | Obligated | Share |
|---|---|---|---|
| 1 | Department of the Army | $213,387 | 57% |
| 2 | Defense Health Agency | $159,780 | 43% |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2020 | -$78,162 |
| FY2019 | $36,708 |
| FY2018 | $414,621 |
Quick answers
What is the Experimental Therapeutics Medicinal Chemistry contract vehicle?
Experimental Therapeutics Medicinal Chemistry is an indefinite delivery, indefinite quantity (IDIQ) contract vehicle run by Medical Command (Department of the Army), awarded on January 18, 2018.
Which companies hold Experimental Therapeutics Medicinal Chemistry?
4 companies hold Experimental Therapeutics Medicinal Chemistry's IDV awards, one each. The latest went to Organix Chemistry Solutions LLC on January 19, 2018. The awardees whose task orders obligated the most are Aapharmasyn LLC, Hager Biosciences, LLC and Organix Chemistry Solutions LLC.
How much has been spent through Experimental Therapeutics Medicinal Chemistry?
5 task orders have been placed under Experimental Therapeutics Medicinal Chemistry, obligating $373,167.
What is the shared ceiling of Experimental Therapeutics Medicinal Chemistry?
Experimental Therapeutics Medicinal Chemistry's shared ceiling is $2,500,000; its task orders have used 15% of it.
Which agencies use Experimental Therapeutics Medicinal Chemistry the most?
The departments whose task orders under Experimental Therapeutics Medicinal Chemistry obligated the most are Department of the Army ($213,387) and Defense Health Agency ($159,780).
On GovTribe
See this vehicle's full record
- Every IDV award and task order
- Funding by agency, awardee, NAICS and set-aside
- Teaming partners on this vehicle
- Ask GovTribe AI about this vehicle